Litcius/Paper detail

Serum soluble mesothelin-related protein (SMRP) and fibulin-3 levels correlate with baseline malignant pleural mesothelioma (MPM) tumor volumes but are not useful as biomarkers of response in an immunotherapy trial

Sharyn I. Katz, Leonid Roshkovan, Ian Berger, Joseph S. Friedberg, Evan Alley, Charles B. Simone, Andrew R. Haas, Keith A. Cengel, Daniel H. Sterman, Steven Μ. Albelda

2021Lung Cancer19 citationsDOI

Topics & Concepts

MedicineMesothelinInternal medicineMesotheliomaClinical trialOncologyProspective cohort studyChemotherapyCancerPathologyOccupational and environmental lung diseasesPleural and Pulmonary DiseasesConnective tissue disorders research
Serum soluble mesothelin-related protein (SMRP) and fibulin-3 levels correlate with baseline malignant pleural mesothelioma (MPM) tumor volumes but are not useful as biomarkers of response in an immunotherapy trial | Litcius